After months of waiting, the news is confirmed. The MHRA has granted marketing authorisation for oral semaglutide for weight management in the UK, making the Wegovy pill the first GLP-1 medication of its kind to be licensed here in tablet form.

For men who've been tracking this story — watching the US launch in January, reading the trial data, or holding off on injections — it's a meaningful development. And from today, it's available through HeMed.

What's actually been approved

The Wegovy pill is a once-daily oral tablet containing semaglutide, the same active ingredient as the Wegovy injection. Developed by Novo Nordisk, it works by mimicking the GLP-1 hormone that regulates appetite and signals fullness — so hunger reduces, food becomes less of a preoccupation, and eating less stops feeling like a discipline exercise.

What's new isn't the molecule. Semaglutide has been available by injection in the UK for several years, and the evidence behind it is well established. The oral version required its own independent MHRA review — separate from the FDA approval granted in the US last December. That process is now complete.

In the OASIS 4 trial, participants taking oral semaglutide lost an average of 16.6% of their body weight over 64 weeks. Higher-dose injectables produce greater average loss — 20.5% for Wegovy and 21% for Mounjaro — but for men who've been avoiding treatment because of the injection, the pill now removes that barrier with a clinically approved alternative.

Why this matters

The injection has always worked. For men who are comfortable with it, nothing changes. But a significant number of men have been reluctant to start — needles, fridge storage, the visibility of a weekly pen. The pill removes all of that.

Once daily, room temperature, no sharps. The dosing routine is specific — empty stomach, no more than half a small glass of water, wait 30 minutes before eating or drinking anything else — but for most men it fits into a morning without much adjustment. Take it before your shower and the window is done before you want coffee.

It won't suit everyone. Shift workers, men with unpredictable mornings, or those on medications that also require fasting administration may find the injection or Mounjaro a better fit. A HeMed clinician will always review this before prescribing.

On dosing, switching and what comes next

The pill starts at 1.5mg and titrates to a maximum of 25mg. Men already on the Wegovy 2.4mg injection can typically switch directly to the 25mg tablet — one week after their last injection, no need to re-titrate from scratch. Same molecule, different format.

Side effects follow a similar pattern to the injection — largely digestive, most common at the start or when increasing dose. Most settle within a few weeks.

Available at HeMed now, with flat-dose pricing

HeMed has the Wegovy pill in stock and available to order today. As with all HeMed treatments, pricing is flat-dose — no escalating costs as your dose increases, which is one of the things that sets HeMed apart from other providers. Every patient starts with a free blood test, a clinician consultation, and a treatment plan built around your health picture.

If you're already on HeMed and want to discuss switching from the injection, your clinical team can advise.

Order the Wegovy pill through HeMed

Oral semaglutide is a prescription-only medication. All treatment decisions are made by a HeMed clinician based on your individual health profile, medication history, and treatment response. This article is for informational purposes only and does not constitute medical advice.

‍